Ceribell (CBLL) Gross Margin (2023 - 2026)

Ceribell (CBLL) reported Gross Margin of 87.27% for Q1 2026, down 61.0% on a YoY basis from 223.78% in Q1 2025, and little changed quarter-over-quarter from 87.33% in Q4 2025.

Ceribell (CBLL) Gross Margin (2023 - 2026) Analysis & Trends

Ceribell has reported Gross Margin for 4 years, with the latest figure at 87.27% in Q1 2026.

  • For the quarter ending Q1 2026, Gross Margin fell 61.0% year-over-year to 87.27%; the trailing twelve-month figure through Mar 2026 stood at 87.72% (up 47.0% YoY), and the FY2025 full-year result was 87.89%, up 117.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 87.27%, roughly flat from 87.33% in the prior quarter.
  • The five-year high for Gross Margin was 88.28% in Q3 2025, with the low at 83.77% in Q3 2023.
  • Historically, Gross Margin has averaged 86.71% across 4 years, with a median of 87.3% in 2024.
  • Annual changes were most pronounced in 2024 — Gross Margin surged 353 bps — and 2026, when it tumbled 61 bps.
  • Ceribell's Gross Margin stood at 84.65% in 2023, then rose by 3 bps to 87.61% in 2024, then dropped by 0 bps to 87.33% in 2025, then declined by 0 bps to 87.27% in 2026.
  • The last three Gross Margin figures came in at 87.27% (Q1 2026), 87.33% (Q4 2025), and 88.28% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 56.20%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 63.29%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 63.83%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 69.46%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 78.01%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 45.22%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 62.95%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 38.53%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 43.89%
10 Ceribell 679.82 Mn 538.64 Mn 23.12 Mn 87.27%

Historic Data

Download Data
DateValue
Mar 31, 2026 87.27%
Dec 31, 2025 87.33%
Sep 30, 2025 88.28%
Jun 30, 2025 88.13%
Mar 31, 2025 87.88%
Dec 31, 2024 87.61%
Sep 30, 2024 87.30%
Jun 30, 2024 85.92%
Mar 31, 2024 85.71%
Dec 31, 2023 84.65%
Sep 30, 2023 83.77%